BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9599229)

  • 1. Structure-activity relationship of 2-[[(2-pyridyl)methyl]thio]-1H- benzimidazoles as anti Helicobacter pylori agents in vitro and evaluation of their in vivo efficacy.
    Kühler TC; Swanson M; Shcherbuchin V; Larsson H; Mellgârd B; Sjöström JE
    J Med Chem; 1998 May; 41(11):1777-88. PubMed ID: 9599229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 1.
    Kühler TC; Swanson M; Christenson B; Klintenberg AC; Lamm B; Fägerhag J; Gatti R; Olwegård-Halvarsson M; Shcherbuchin V; Elebring T; Sjöström JE
    J Med Chem; 2002 Sep; 45(19):4282-99. PubMed ID: 12213070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
    Chang CS; Liu JF; Lin HJ; Lin CD; Tang CH; Lu DY; Sing YT; Chen LY; Kao MC; Kuo SC; Lai CH
    Eur J Med Chem; 2012 Feb; 48():244-54. PubMed ID: 22217866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Helicobacter pylori agents. 1. 2-(Alkylguanidino)-4-furylthiazoles and related compounds.
    Katsura Y; Tomishi T; Inoue Y; Sakane K; Matsumoto Y; Ishikawa H; Takasugi H
    J Med Chem; 1997 Aug; 40(16):2462-5. PubMed ID: 9258352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori.
    Shirin H; Moss SF; Kancherla S; Kancherla K; Holt PR; Weinstein IB; Sordillo EM
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1388-93. PubMed ID: 16911681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori.
    Zaidi SF; Yamada K; Kadowaki M; Usmanghani K; Sugiyama T
    J Ethnopharmacol; 2009 Jan; 121(2):286-91. PubMed ID: 19041711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents.
    Moshafi MH; Sorkhi M; Emami S; Nakhjiri M; Yahya-Meymandi A; Negahbani AS; Siavoshi F; Omrani M; Alipour E; Vosooghi M; Shafiee A; Foroumadi A
    Arch Pharm (Weinheim); 2011 Mar; 344(3):178-83. PubMed ID: 21384417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori.
    Spengler G; Molnar A; Klausz G; Mandi Y; Kawase M; Motohashi N; Molnar J
    Int J Antimicrob Agents; 2004 Jun; 23(6):631-3. PubMed ID: 15194136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urea, fluorofamide, and omeprazole treatments alter helicobacter colonization in the mouse gastric mucosa.
    Aristoteli LP; O'Rourke JL; Danon S; Larsson H; Mellgard B; Mitchell H; Lee A
    Helicobacter; 2006 Oct; 11(5):460-8. PubMed ID: 16961809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
    Carcanague D; Shue YK; Wuonola MA; Uria-Nickelsen M; Joubran C; Abedi JK; Jones J; Kühler TC
    J Med Chem; 2002 Sep; 45(19):4300-9. PubMed ID: 12213071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles.
    Katsura Y; Nishino S; Ohno M; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
    J Med Chem; 1999 Jul; 42(15):2920-6. PubMed ID: 10425101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain.
    Foroumadi A; Rineh A; Emami S; Siavoshi F; Massarrat S; Safari F; Rajabalian S; Falahati M; Lotfali E; Shafiee A
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3315-20. PubMed ID: 18442909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles.
    Letafat B; Emami S; Aliabadi A; Mohammadhosseini N; Moshafi MH; Asadipour A; Shafiee A; Foroumadi A
    Arch Pharm (Weinheim); 2008 Aug; 341(8):497-501. PubMed ID: 18618489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: a novel pro-drug approach to increase exposure.
    Basarab GS; Hill PJ; Rastagar A; Webborn PJ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4716-22. PubMed ID: 18640833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Helicobacter pylori activity of derivatives of the phthalide-containing antibacterial agents spirolaxine methyl ether, CJ-12,954, CJ-13,013, CJ-13,102, CJ-13,104, CJ-13,108 and CJ-13,015.
    Radcliff FJ; Fraser JD; Wilson ZE; Heapy AM; Robinson JE; Bryant CJ; Flowers CL; Brimble MA
    Bioorg Med Chem; 2008 Jun; 16(11):6179-85. PubMed ID: 18457954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.
    Park BS; Lee HK; Lee SE; Piao XL; Takeoka GR; Wong RY; Ahn YJ; Kim JH
    J Ethnopharmacol; 2006 Apr; 105(1-2):255-62. PubMed ID: 16359837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids with anti-Helicobacter pylori activity from Cistus laurifolius leaves.
    Ustün O; Ozçelik B; Akyön Y; Abbasoglu U; Yesilada E
    J Ethnopharmacol; 2006 Dec; 108(3):457-61. PubMed ID: 16870372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on anti-Helicobacter pylori agents. Part 3: A novel, efficacious cephem derivative, FR193879.
    Yoshida Y; Matsuda K; Sasaki H; Matsumoto Y; Matsumoto S; Tawara S; Takasugi H
    Bioorg Med Chem Lett; 2004 May; 14(10):2627-31. PubMed ID: 15109666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
    J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antimicrobial effects of several isothiocyanates on Helicobacter pylori.
    Haristoy X; Fahey JW; Scholtus I; Lozniewski A
    Planta Med; 2005 Apr; 71(4):326-30. PubMed ID: 15856408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.